{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:05:31Z","timestamp":1792065931856,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EU-funded Hungarian grant","award":["EFOP-3.6.1-16-2016-00008 and <GN1>G"],"award-info":[{"award-number":["EFOP-3.6.1-16-2016-00008 and <GN1>G"]}]},{"name":"EU-funded Hungarian grant","award":["INOP-2.3.2-15-2016-00060,"],"award-info":[{"award-number":["INOP-2.3.2-15-2016-00060,"]}]},{"name":"Ministry of Human Capacities of Hungary grant No.","award":["\u00daNKP-19-3-SZTE-266."],"award-info":[{"award-number":["\u00daNKP-19-3-SZTE-266."]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jpba.2020.113615","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T03:00:33Z","timestamp":1599620433000},"page":"113615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application"],"prefix":"10.1016","volume":"191","author":[{"given":"T\u00edmea","family":"K\u00f6rm\u00f6czi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdrisz","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botond","family":"Penke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Jan\u00e1ky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Ilisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Berkecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2020.113615_bib0005","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1038\/s41598-019-45812-w","article-title":"Biosynthesis and extracellular concentrations of N,Ndimethyltryptamine (DMT) in mammalian brain","volume":"9","author":"Dean","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jpba.2020.113615_bib0010","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/bmc.2981","article-title":"LC\/MS\/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate","volume":"27","author":"Barker","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"2","key":"10.1016\/j.jpba.2020.113615_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1192\/bjp.132.2.139","article-title":"Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations","volume":"132","author":"Corbett","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpba.2020.113615_bib0020","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/2061052a0","article-title":"N-dimethyltryptamine, n,n-dimethyl-5-hydroxytryptamine and 5-methoxytrytamine in human blood and urine","volume":"206","author":"Franzen","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2020.113615_bib0025","series-title":"The Touristic Use of Ayahuasca in Peru. Sozialwissenschaftliche Gesundheitsforschung","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-658-29373-4","author":"Wolff","year":"2020"},{"issue":"12","key":"10.1016\/j.jpba.2020.113615_bib0030","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J. Neural Transm."},{"issue":"10","key":"10.1016\/j.jpba.2020.113615_bib0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/WNR.0000000000000162","article-title":"Antidepressant fluvoxamine reduces cerebral infarct volume and ameliorates sensorimotor dysfunction in experimental stroke","volume":"25","author":"Sato","year":"2014","journal-title":"NeuroReport"},{"key":"10.1016\/j.jpba.2020.113615_bib0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fnins.2016.00423","article-title":"The endogenous hallucinogen and trace amine N,N dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells","volume":"10","author":"Szabo","year":"2016","journal-title":"Front. Neurosci."},{"issue":"7\u20138","key":"10.1016\/j.jpba.2020.113615_bib0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N, N\u2010dimethyltryptamines in humans: 1955\u20132010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2020.113615_bib0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00365510510013604","article-title":"Potentially hallucinogenic 5\u2010hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues","volume":"65","author":"K\u00e4rkk\u00e4inen","year":"2005","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"issue":"1","key":"10.1016\/j.jpba.2020.113615_bib0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0269881117736919","article-title":"N, N-dimethyltryptamine and the pineal gland: separating fact from myth","volume":"32","author":"Nichols","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpba.2020.113615_bib0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.aca.2019.09.068","article-title":"Mixed-mode chromatography characteristics of chiralpak ZWIX (+) and ZWIX (\u2212) and elucidation of their chromatographic orthogonality for LC\u00d7 LC application","volume":"1093","author":"B\u00e4urer","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2020.113615_bib0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpba.2017.10.043","article-title":"Comprehensive phospholipid and sphingomyelin profiling of different brain regions in mouse model of anxiety disorder using online two-dimensional (HILIC\/RP)-LC\/MS method","volume":"149","author":"Berkecz","year":"2018","journal-title":"J. Pharmaceut. Biomed."},{"key":"10.1016\/j.jpba.2020.113615_bib0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpba.2016.09.010","article-title":"Application of on-line and off-line heart-cutting LC in determination of secondary metabolites from the flowers of Lonicera caerulea cultivar varieties","volume":"131","author":"Kula","year":"2016","journal-title":"J. Pharmaceut. Biomed."},{"issue":"1","key":"10.1016\/j.jpba.2020.113615_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-4347(00)00442-4","article-title":"Distribution of the hallucinogens N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC\u2013APcI\u2013MS\u2013MS\u2013isotope dilution method","volume":"751","author":"Barker","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"14","key":"10.1016\/j.jpba.2020.113615_bib0080","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.4155\/bio.12.124","article-title":"Determination of dimethyltryptamine and \u03b2-carbolines (ayahuasca alkaloids) in plasma samples by LC\u2013MS\/MS","volume":"4","author":"Oliveira","year":"2012","journal-title":"Bioanalysis"},{"issue":"1","key":"10.1016\/j.jpba.2020.113615_bib0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00216-013-7425-9","article-title":"A qualitative\/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 \u03b2-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches","volume":"406","author":"Meyer","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2020.113615_bib0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bmc.1657","article-title":"Methodology for determining major constituents of ayahuasca and their metabolites in blood","volume":"26","author":"McIlhenny","year":"2012","journal-title":"Biomed. Chromatogr."},{"issue":"12","key":"10.1016\/j.jpba.2020.113615_bib0095","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jssc.200600199","article-title":"Hydrophilic interaction chromatography","volume":"29","author":"Hemstr\u00f6m","year":"2006","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2020.113615_bib0100","series-title":"Dimethyltryptamine Bioinformatics and Cheminformatics Data, Drugbank","year":"2020"},{"key":"10.1016\/j.jpba.2020.113615_bib0105","series-title":"Indopan Bioinformatics and Cheminformatics Data, Drugbank","year":"2020"},{"issue":"1","key":"10.1016\/j.jpba.2020.113615_bib0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-2944(73)90014-8","article-title":"Gas chromatographic-mass spectrometric isotope dilution assay for N, N-dimethyltryptamine in human plasma","volume":"8","author":"Walker","year":"1973","journal-title":"Biochem. Med."},{"issue":"1","key":"10.1016\/j.jpba.2020.113615_bib0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-3565(25)31309-1","article-title":"Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography","volume":"206","author":"Riceberg","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2020.113615_bib0120","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212 MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2020.113615_bib0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/mas.20298","article-title":"An overview of matrix effects in liquid chromatography\u2013mass spectrometry","volume":"30","author":"Trufelli","year":"2011","journal-title":"Mass Spectrom. Rev."},{"issue":"1","key":"10.1016\/j.jpba.2020.113615_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J. Appl. Toxicol."},{"issue":"5\u20136","key":"10.1016\/j.jpba.2020.113615_bib0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pneurobio.2006.07.003","article-title":"The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain","volume":"79","author":"Burchett","year":"2006","journal-title":"Prog. Neurobiol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520315016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520315016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:08:28Z","timestamp":1760000908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520315016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"alternative-id":["S0731708520315016"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113615","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113615"}}